Data Foundry

Drug recalls 2014

Heparin Sodium Injection — Class II drug recall D-1148-2014

Terminated recall by Fresenius Kabi USA, LLC, reported 2014-03-12, distributed nationwide. Subpotent; 18 month time point

Recall numberD-1148-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmFresenius Kabi USA, LLC, Grand Island, NY, United States
Recall initiated2014-01-22
Classified2014-03-05
Reported by FDA2014-03-12
Terminated2016-05-24
DistributedNationwide (US)
Quantity161,650 vials
Reason classespotency
NDC63323-0047, 63323-0047-01, 63323-0047-10, 63323-0262, 63323-0262-01, 63323-0276, 63323-0276-01, 63323-0276-02, 63323-0459, 63323-0459-09, 63323-0540, 63323-0540-01, 63323-0540-11, 63323-0540-31, 63323-0542, 63323-0542-01, 63323-0542-07, 63323-0543, 63323-0543-02, 63323-0915, 63323-0915-01
Lot numbers6004137
Expiration dates2014-06

Product

Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11, 25 vials in tray, each boxed vial individually labeled as: Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11.

Reason for recall

Subpotent; 18 month time point

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1148-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.